NIH Research Chemist · 1910–1999

The legacy of Dr. Harry W. Diehl, PhD

The National Institutes of Health chemist who isolated and synthesized cetyl myristoleate (CM8) — the joint-support compound that began with a simple question: why do some mice never develop arthritis?

A chemist’s legacy

A career spent making things, and one discovery that outlasted them all.

Dr. Diehl developed hundreds of compounds across a long career at the NIH. He is best remembered for one he wasn’t even looking for.

NIH chemist

Four decades at the National Institutes of Health, where his specialty was sugar synthesis — not arthritis.

∙∙

An unexpected lead

While studying why certain mice resisted induced arthritis, he traced the protection to a single fatty-acid ester.

∙∙∙

Isolated & synthesized

Using thin-layer chromatography he identified cetyl myristoleate, then recreated it in the lab by esterification.

§

Documented

His findings were published in 1994 and protected by three U.S. patents granted between 1977 and 1996.

2-deoxy-D-ribose

An earlier synthesis of his supported mid-century polio-vaccine research — one of several contributions to public health.

A personal stake

Diehl developed arthritis himself late in life and, by his own account, prepared the compound for his own use.

From the lab bench to the market

The milestones of a single discovery.

1958

Develops a synthesis of 2-deoxy-D-ribose, a sugar relevant to the polio-vaccine research of the era.

Early 1960s

Turns his attention to arthritis after a friend develops a severe case — well outside his field of sugar chemistry.

1977

Isolates and synthesizes cetyl myristoleate; granted his first U.S. patent (No. 4,049,824).

1978 & 1996

Two further U.S. patents follow, covering methods related to rheumatoid arthritis and osteoarthritis.

1994

Diehl & May publish their findings in the Journal of Pharmaceutical Sciences (Vol. 83).

1990s

Cetyl myristoleate reaches the U.S. supplement market as a joint-support ingredient.

1999

Dr. Harry W. Diehl passes away at the age of 89.